Narrative review / 2021
OARSI and ESCEO guidelines both recommend weight loss and exercise for knee OA but diverge on glucosamine and chondroitin sulfate.
This narrative review compares the updated 2019 OARSI and ESCEO guidelines for the non-surgical management of knee osteoarthritis. Both guidelines recommend education, structured exercise, and weight loss as core treatments, topical NSAIDs as first-line treatments, and oral NSAIDs and intra-articular injections for persistent pain. Low-dose, short-term acetaminophen, pharmaceutical grade glucosamine, and chondroitin sulfate are recommended by ESCEO, whereas OARSI strongly recommends against their use (including all glucosamine and chondroitin formulations).
- Study type
- Guideline comparison review
- Who was studied
- Guidelines for patients with knee osteoarthritis
- What was measured
- Non-surgical management recommendations for knee osteoarthritis
THE PAPER
Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines.
Arden NK, Perry TA, Bannuru RR, Bruyère O, Cooper C, Haugen IK, Hochberg MC, McAlindon TE, Mobasheri A, Reginster JY. Nat Rev Rheumatol, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.